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Abstract
Purpose Short-term complications related to the perineal
wound after abdominoperineal excision (APE) are a well-
known problem. Perineal morbidity in the longer term is an
almost unexplored area. The aim of this cross-sectional study
was to investigate the prevalence of perineal symptoms 3 years
after APE for rectal cancer, to identify potential risk factors
and to explore the relationship between perineal morbidity
and global quality of life.
Method All patients who underwent APE in Sweden between
2007 and 2009 (n=1373) were identified through the Swedish
Colorectal Cancer Registry. Surviving patients were contacted
3 years after surgery and asked about participation. A total of
545 patients completed a detailed questionnaire. Clinical data
was collected from the registry and surgical charts.
Results Perineal symptoms occurred in 50 % of all patients
3 years after APE andmore frequently in women (58 vs. 44%;
p=0.001). Delayed healing of the perineal wound (>4 weeks)
occurred in 25 % of all patients and more frequently after
extralevator APE (ELAPE) than after conventional APE (32
vs. 11 %, p<0.001). Delayed healing was associated with an
increased risk of more severe perineal symptoms (relative risk
(RR) 1.50, 95 % confidence interval (95 % CI) 1.09–2.05).
Patients with more severe perineal symptoms (n=129) had a
significantly lower global quality of life as measured by EQ-
5D visual analogue scale (VAS; median 75 vs. 83 points on
the 100-point scale; p<0.001).
Conclusion Persistent perineal symptoms are common after
APE and may have an impact on patients’ quality of life.
Delayed wound healing may be a risk factor for persistent
symptoms. Further studies are needed to identify avoidable
clinical factors for the development of persistent perineal
morbidity.
ClinicalTrials.gov Identifier NCT01296984
Keywords Rectal cancer . Abdominoperineal excision .
Perineal morbidity . Quality of life
Introduction
Treatment of patients with distal rectal cancer is a clinical
challenge. Achieving an optimal oncologic result is para-
mount, but functional consequences of treatment must also
be considered. Recently, several studies have focused on the
proposed oncological advantage of extra levator
abdominoperineal excision (ELAPE) compared to conven-
tional abdominoperineal excision (conventional APE) [2, 7,
17, 18, 24, 26]. Other studies have investigated functional
aspects of these procedures such as sexual and urological dys-
function [6, 9] and stoma-related problems [1, 14].
The occurrence and implications of perineal symptoms fol-
lowing abdominoperineal excision is a largely unexplored ar-
ea. One study found persistent perineal pain in half of all
patients 2 years after ELAPE [23]. Reports of other long-
term perineal symptoms are scarce. In contrast, short-term
perineal morbidity after abdominoperineal excision is well
documented. Several studies have reported increased perineal
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wound complications after ELAPE compared to conventional
APE [2, 7, 11, 13, 18, 24, 25]. Perineal wound complications
frequently result in delayed healing, but whether this is asso-
ciated with persistent perineal symptoms is not known.
We hypothesized that persistent perineal symptoms are fre-
quent following any kind of abdominoperineal excision. In the
present analysis, we explored the prevalence of perineal
symptoms about 3 years after surgery in a national cohort.
The primary objective was to determine the prevalence and
severity of symptoms, and secondary objectives were to iden-
tify risk factors for long-term perineal morbidity and to inves-
tigate the impact of perineal morbidity on patients’ health-
related quality of life. Oncologic results in this national cohort,
including 3-year recurrence rates, have been reported previ-
ously [17–19].
Methods
In this registry-based, observational study, patients operated
with abdominoperineal excision for rectal cancer in Sweden in
the years 2007–2009 were identified through the Swedish
Colorectal Cancer Registry. This national quality registry
covers more than 97 % of all patients in Sweden and has a
good internal validity [8, 15]. Data on sex, age, BMI, Amer-
ican Society of Anesthesiologists (ASA) classification, tumor
height (distance from the lower edge of the tumor to the anal
verge), neoadjuvant treatment, circumferential resection mar-
gin (CRM) involvement, and tumor pT and pN stage were
retrieved from the registry. Data regarding perineal dissection
and reconstruction techniques were not included in the regis-
try but was extracted from operative notes [19]. This allowed
for the classification of procedures as either conventional APE
or ELAPE in a majority of cases, but surgical technique
remained interminable in as many as 252 cases. Information
regarding perineal symptoms after surgery was obtained
through a study-specific questionnaire.
Questionnaire
The questions on perineal symptoms (Table 1) analyzed in the
present study were part of an extensive questionnaire that also
covered many other aspects of functional outcome after
abdominoperineal excision. The development and validation
of this questionnaire is illustrated in Fig. 1 and has been de-
scribed in detail elsewhere [3, 10, 12, 21, 22]. The process
involved interviewswith rectal cancer patients and subsequent
analysis with qualitative methods, content validation in a mul-
tidisciplinary group of professionals with extensive clinical
experience in the field, and face-to-face validation, whereTable 1 Questions on perineal symptoms and perineal wound healing
Perineal symptoms
Have you had pain between the buttocks in the past month?
Have you had difficulties to sit in the past month?
Have you had loss of sensation/numbness in the buttocks in the
past month?
Have you experienced tension in the buttocks in the past month?
Have you experienced a tingling/stinging sensation in the buttocks
in the past month?
Have you experienced cramps/urgency that you perceived came
from the previous location of your rectum in the past month?
Response options: Not at all/a little/quite a bit/very much
Perineal wound healing
For how long after your rectal surgery did you need to irrigate or
change the dressing of the wound between the buttocks, at home
or at a primary care centre/hospital?
Response options: 2 weeks/3–4 weeks/1–2 months/3–4 months/longer
than 4 months
What was your experience of the wound healing process after your rectal
surgery, when the wound between the buttocks was healing?
Response options: Not at all difficult/a little difficult/quite
difficult/very difficult
Questions on symptom-associated distress (exemplified by the
question regarding pain)
If you, for the rest of your life, would have as much pain between the
buttocks as you did in the past month, would that distress you?
Response options: Not applicable, I have not had pain between the
















Fig. 1 Development of a study-specific questionnaire
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patients were asked to complete the questionnaire in the pres-
ence of a specialist nurse to detect any problems, misinterpre-
tations, or concerns. Questions were revised accordingly, and
the process continued until no uncertainties remained.
During the development of the questionnaire, six Bcore^
perineal symptoms emerged and were included in this analy-
sis: pain, sitting disability, paraesthesia, tension between the
buttocks, sensation of tingling/stinging between the buttocks,
and perineal cramps/sensation of urgency. The recall period
was the past month. Response options were dichotomized as
explained in the tables. Patients reporting at least one perineal
symptom of severe intensity (response options quite a bit or
very much, see Table 1) were defined by us to have a severe
perineal morbidity.
Also included in this analysis were questions on post-
operative perineal wound healing and the EQ-5D visual ana-
logue scale (VAS) question on global health-related quality of
life [4, 16, 20].
Statistical analyses
All data were collected in a database, and statistical analyses
were performed using SPSS 21.0 (IBM SPSS Inc. Armonk,
NY, USA) and SAS v. 9 (SAS institute). In the analysis of risk
factors for severe perineal morbidity (the experience of one or
more symptom of severe intensity, see above), variables cho-
sen as potential predictors were radiotherapy, sex, age, tumor
height, and delayed perineal wound healing. Because of the
observed strong association between surgical technique and
perineal wound healing (Table 2), surgical technique was not
included in the regression model. In the subgroup of patients
who underwent ELAPE, perineal repair and excision of the
coccyx were included as potential predictors as well. A log-
linear binomial regression model [5] was used to estimate the
relative risk (RR) and 95 % confidence intervals (95 % CIs).
In case the binomial model did not converge, a log-linear
Poisson regression with a robust error variance was used
[27]. Additional statistical analyses involved chi-square test
and Mann–WhitneyU test for categorical and continuous var-
iables, respectively. No correction for multiple testing was
made, and results should therefore be regarded as interesting
findings rather than as conclusive evidence.
Results
Out of the 1319 patients who were included in our
previous analyses of oncological outcome [17, 18],
1373 cases of abdominoperineal excision for 
rectal cancer  in Sweden 2007-2009
Surgical notes unavailable, n=54
Unable (mentally or physically) to 
parcipate, n = 91
Lost to follow-up,  n=58 
703 eligible  paents
545 paents returned a completed 
quesonnaire and were included in the 
analysis
Deceased, n=467
Introductory leer sent to 852 paents, 
followed by a phone call
1319 paents
Quesonnaire not returned, n=51
Included in the analysis of 
oncological outcome (Prytz et al 
2014 and 2015)
Quesonnaire sent to 596 paents
No consent, n=107
Fig. 2 Flowchart of patients
Table 2 Time to healing of the
perineal wound stratified on
surgical technique
Conventional APE ELAPE p value Missing
Time to healing (%) Normal 0–4 weeks 62 (88.6 %) 146 (68.2 %) 0.001a 9
Delayed 1–4 months 6 (8.6 %) 48 (22.4 %)
>4 months 2 (2.9 %) 20 (9.3 %)
Patients operated with an indeterminate surgical technique (n=252) are omitted
APE abdominoperineal excision, ELAPE extralevator abdominoperineal excision
a normal versus delayed (>4 weeks) healing
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852 were alive 3 years post-operatively and 703 patients
were eligible for inclusion in this study (Fig. 2). A total
of 596 patients agreed to receive the questionnaire by
mail and 545 returned the questionnaire and were in-
cluded in the analysis. Reasons for non-inclusion (n=
774) are presented in Fig. 2. Clinical characteristics of
included patients, non-responders, and deceased patients
are presented in Table 3. Non-responders were older and
had more comorbidity as reflected by the preoperative
ASA grade and received less neoadjuvant radiotherapy
than responders to the questionnaire. Conventional APE
was more common among non-responders, as were in-
volved resection margins.
The conventional APE and ELAPE groups differed
regarding sex and tumor height, with more male patients
and more distal tumors in the ELAPE group. The frequen-
cy of coccyx resection and method of perineal repair also
differed between groups with very few resections and no
use of flap or mesh in the conventional APE group. pT
and pN stage and ASA grade were no different, and there
were no significant differences regarding neoadjuvant
radiotherapy and chemoradiotherapy (Table 4).
Table 3 Clinical characteristics of patients operated by abdominoperineal excision in Sweden 2007–2009
Total cohort, n=1319
Included in the analysis Deceased at follow-up Non-responders p value
Number of patients 545 467 307
Sex Female 218 (40.0 %) 170 (36.4 %) 142 (46.3 %) 0.076
Male 327 (60.0 %) 297 (63.6 %) 165 (53.7 %)
Age at operation 66.0 71.9 69.3 <0.001
BMI 29.3 27.3 26.8 0.944
ASA classification ASA 1 144 (27.0 %) 69 (15.3 %) 61 (20.5 %) <0.001
ASA 2 314 (58.9 %) 235 52.2 %) 165 (55.4 %)
ASA 3 73 (13.7 %) 137 (30.4 %) 72 (24.2 %)
ASA 4 2 (0.4 %) 9 (2.0 %) 0
Radiation therapy None 64 (11.8 %) 123 (26.7 %) 64 (20.9 %) <0.01
Short (5×5 Gy) 355 (65.6 %) 222 (48.2 %) 181 (59.2 %)
Long (25×1,8/2 Gy) 122 (22.6 %) 116 (25.2 %) 61 (19.9 %)
Chemoradiotherapy Yes 110 (20.2 %) 112 (24.0 %) 57 (18.6 %) 0.560
No 434 (79.8 %) 354 (76 %) 250 (81.4 %)
Tumor heighta 4,1 4,3 4,3 0.811
pT stage T0–T2 256 (47.9 %) 98 (21.2 %) 130 (42.9 %) 0.385
T3 252 (47.1 %) 289 (62.4 %) 156 (51.5 %)
T4 27 (5.0 %) 76 (16.4 %) 17 (5.6 %)
pN stage N0 344 (63.9 %) 187 (41.1 %) 202 (68.2 %) 0.354
N1 130 (24.2 %) 117 (25.7 %) 67 (22.6 %)
N2 64 (11.9 %) 151 (33.2 %) 27 (9.1 %)
Microscopic radicalityb Yes 522 (96.0 %) 386 (83.0 %) 285 (92.8 %) <0.05
No/indeterminate 22 (4.0 %) 79 (17.0 %) 22 (7.2 %)
Perineal dissection Conventional APE 71 (13.0 %) 79 (16.9 %) 59 (19.2 %) <0.05
ELAPE 222 (40.7 %) 172 (36.8 %) 124 (40.45)
Indeterminate 252 (46.2 %) 216 (46.3 %) 124 (40.4 %)
Coccyx resection Yes 124 (27.7 %) 133 (35.6 %) 73 (28.4 %) 0.850
No 323 (72.3 %) 241 (64.4 %) 184 (71.6 %)
Perineal reconstruction Suture 430 (79.6 %) 352 (76.4 %) 238 (78.3 %) 0.803
Mesh 64 (11.9 %) 56 (12.1 %) 36 (11.8 %)
Flap 46 (8.5 %) 53 (11.5 %) 30 (9.9 %)
p values refer to differences between included patients and non-responders
BMI body mass index, ASA American Society of Anesthesiologists, APE abdominoperineal excision, ELAPE extralevator abdominoperineal excision
a Distance in centimeter from the lower edge of the tumor to the anal verge
b Circumferential resection margin >1 mm
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Perineal symptoms and associated distress
Perineal symptoms were present in 50 % of all responding
patients and more frequently in women (58 vs. 44 %; p=
0.001). In total, 129 patients (24 %) experienced one or more
perineal symptom of severe intensity, i.e., severe perineal mor-
bidity according to our definition.
Tension between buttocks, sitting disability, cramps/urgen-
cy, and perineal pain were most frequently experienced
(Table 5). Sitting disability was particularly distressful to pa-
tients. There was a positive relationship between the symptom
intensity and the level of associated distress for all symptoms
(data not shown).
Perineal wound healing
A total of 133 patients (25%) reported delayed wound healing
(>4 weeks) following their operation (Table 6). The wound
healing process was associated with a high level of distress in
46 % of the patients. There was a positive relationship
between the duration of the healing process and the
level of associated distress (data not shown). Time to
healing of the perineal wound was significantly related
to surgical technique (Table 2). The relative risk of a
delayed healing after ELAPE compared to conventional
APE was 3.45 (95 % CI 1.46–8.15) after adjustment for
smoking, diabetes, BMI, and preoperative radiotherapy.
Radiotherapy alone was not associated with delayed
healing in bivariate analysis.
Risk factors for perineal symptoms
Delayed perineal wound healing and female gender were sta-
tistically significant risk factors for severe perineal morbidity
whereas no significant contribution could be observed for the
other variables including radiotherapy (Table 7). In a sub-
group of ELAPE patients, plain suturing and flap reconstruc-
tion both increased the risk of severe perineal morbidity
Table 5 Perineal symptoms: prevalence, intensity, and associated distress
Symptoms Symptom-associated distress
None Any intensity Minor/severea Missing None or lowb Highc Missingd
Pain 419 (79 %) 114 (21 %) 76 (14 %)/38 (7 %) 12 63 (62 %) 38 (38 %) 13
Sitting disability 410 (77 %) 123 (23 %) 81 (15 %)/42 (8 %) 12 57 (55 %) 47 (45 %) 19
Paraesthesia 461 (86 %) 76 (14 %) 53 (10 %)/23(4 %) 8 50 (68 %) 23 (32 %) 3
Tension 400 (75 %) 132 (25 %) 96 (18 %)/36 (7 %) 13 98 (75 %) 32 (25 %) 2
Tingling/stinging 490 (93 %) 40 (7 %) 33 (6 %)/7 (1 %) 15 28 (72 %) 11 (28 %) 1
Cramps/urgency 412 (77 %) 123 (23 %) 101 (19 %)/22 (4 %) 10 100 (82 %) 22 (18 %) 1
a Response options: a little/ quite a bit or very much
b Response options: not at all or a little
c Response options: quite a bit or very much
d Number of symptomatic patients who did not respond to the distress question
Table 4 Clinical characteristics
of responders stratified on
surgical technique
Conventional APE ELAPE p value
Number of patients 71 222
Sex Female 38 (53.5 %) 87 (39.2 %) <0.05
Male 33 (46.5 %) 135 (60.8 %)
Tumor heighta 5,9 3.5 <0.001
Coccyx resection Yes 2 (3.0 %) 95 (46.6 %) <0.001
No 64 (97.0 %) 109 (53.4 %)
Perineal reconstruction: Suture 71 (100.0 %) 120 (54.5 %) <0.001
Mesh 0 54 (24.5 %)
Flap 0 46 (20.9 %)
Patients operated with an indeterminate surgical technique (n=252) are omitted. Age, BMI, ASA grade, neoad-
juvant treatment, pT and pN stage, and non-radical resections did not differ (data not shown)
APE abdominoperineal excision, ELAPE extralevator abdominoperineal excision
a Distance in centimeter from the lower edge of the tumor to the anal verge
Int J Colorectal Dis (2015) 30:1563–1570 1567
compared with mesh repair. Resection of the coccyx did not
have a significant impact (Table 8).
Perineal morbidity and quality of life
Patients who experienced one or more symptom of severe
intensity (i.e., the group of 129 patients with severe perineal
morbidity) had a significantly lower global quality of life as
measured by EQ-5D VAS compared to those with less severe
symptoms (median 75 vs. 83 points on the 100-point scale;
p<0.001).
Discussion
This study showed that 50 % of patients had perineal symp-
toms 3 years after surgery. Tension between buttocks, sitting
disability, perineal cramps/sensation of urgency, and perineal
pain were most frequently experienced, and sitting disability
was associated with most distress. A delayed perineal wound
healing emerged as a risk factor for persistent perineal symp-
toms in our analysis. Delayed healing was considerably more
common after ELAPE compared to conventional APE with
more than three times higher risk in ELAPE patients. Notably,
this did not translate into more long-term perineal symptoms
in ELAPE patients (data not shown). Finally, the experience of
one or more perineal symptom of severe intensity was associ-
ated with a significantly lower global quality of life score in
the EQ-5D visual analogue scale.
Several studies have reported high rates of short-term per-
ineal wound complications after abdominoperineal excision in
general and ELAPE in particular [11, 24], but few have ex-
plored long-term perineal morbidity in these patients. Musters
et al. [11] found a perineal hernia or a persisting perineal sinus
in 8–10 % of patients about 2 years after any kind of
abdominoperineal excision. Welsch and colleagues [23] re-
ported a frequency of persistent pain or other (unspecified)
functional deficits of 50 % after ELAPE about 2 years after
surgery. However, these studies are limited by small sample
sizes, varying follow-up times, and lack of detail regarding
perineal symptoms.
The present study is large in comparison to most other
studies. It combines data from three different relevant sources.
Included patients were collected from a prospective national
registry with almost complete coverage, which strengthens the
external validity. Original operative notes were retrieved and
systematically analyzed, and finally, we used data on patients’
self-reported symptoms at a defined time point after surgery.
In this way, we avoided the pitfalls of retrieving information
on symptoms from hospital records, with their inherent bias
and inconsistency of symptom documentation. This enables
us to draw reliable conclusions.
We did not attempt to design an instrument to reflect peri-
neal morbidity in a single score; instead, questions were ana-
lyzed individually. Patients were queried not only about the
intensity of symptoms but also about the perceived signifi-
cance (symptom-associated distress) of symptoms. Although
not a new concept in oncologic and epidemiologic research
Table 7 Analysis of risk factors for severe perineal morbidity
(corrected for age)
Relative risk 95 % CI
Radiotherapy Yes/no 0.816 0.455–1.463
Sex Female/male 1.35 1.035–1.890
Perineal wound healing Delayed/normal 1.546 1.132–2.111
Tumor height >4 cm/0–4 cm 1.142 0.832–1.567
One or more perineal symptom of severe intensity (response options:
quite a bit or very much)
CI confidence interval
Table 6 Time to healing of the
perineal wound and patients’
perception of the healing process
All Missing
Time to healing (%) Normal 0–4 weeks 391 (75 %) 21
Delayed 1–4 months 91 (17 %)
>4 months 42 (8 %)
Patients’ perception of the healing process Not at all/a little difficult 284 (54 %) 21
Quite/very difficult 240 (46 %)
Table 8 Subgroup analysis of risk factors for severe perineal morbidity
in ELAPE patients (corrected for age)
Relative risk 95 % CI
Perineal repair Suture/mesh 2.311 1.023–5.222
Flap/mesh 3.16 1.284–7.778
Suture/flap 0.731 0.409–1.309
Excision of coccyx Yes/no 1.078 0.440–2.640
Radiotherapy Yes/no 1.484 0.727–3.028
Sex Female/male 0.968 0.603–1.554
Perineal wound healing Delayed/normal 1.624 1.001–2.636
Tumor height >4 cm/0–4 cm 1.149 0.684–1.931
One or more perineal symptom of severe intensity (response options:
quite a bit or very much)
CI confidence interval
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[21, 22], it has seldom been studied in patients with rectal
cancer before.
We have used the term severe perineal morbidity, defined
as the experience of at least one symptom of severe intensity,
in order to identify patients with more severe perineal symp-
toms. This definition is arguably arbitrary but it is clinically
reasonable in our opinion.
Healing of the perineal wound was defined as delayed
if the process exceeded 1 month. Wound healing is diffi-
cult to study; once patients have been discharged, outpa-
tient visits are generally few and wound care is often
carried out in a primary care setting. In our study, time
to healing of the perineal wound was a patient-reported
variable. We asked about the period of time during which
the patient needed wound care after the operation, either
at home, in a hospital, or at a primary care facility. This
should correspond well with the time it took for the
wound to heal. Although there is a risk of recall bias
regarding this outcome, we believe that patients, even
after 3 years, are able to give a fair estimate of the dura-
tion of the healing process, as it is often distressful. No-
tably, healing time did not differ significantly between
patients receiving radiotherapy short course, long course,
or not at all (data not shown).
The differences between responders and non-responders
presented in Table 3 should be considered in relation to the
generalizability of results. Non-responders were older with
more comorbidity and fewer received radiotherapy compared
with responders. However, whether these differences lead to
overestimation or underestimation of perineal morbidity in the
total population of 3-year survivors is unclear.
Although there are missing data for most variables and
questions, numbers are low and should not disturb
interpretation.
The retrospective non-randomized cross-sectional design
has limitations. Baseline data on perineal symptoms are not
available. However, this is probably not a major concern as
perineal symptoms before treatment are likely to be infre-
quent. An alternative study design would be a prospective
observational study. We are currently running such a study
in 16 centers in Sweden and Denmark, but as inclusion is still
ongoing, long-term follow-up results are not available [3].
For the long-term management of patients treated for distal
rectal cancer, solid data on functional impairments are valu-
able.We present such data regarding perineal symptoms based
on a national cancer registry for the first time. We conclude
that the prevalence of persistent perineal symptoms is high
following abdominoperineal excision. This should be con-
veyed to patients as part of the preoperative counselling along
with information about other potential functional conse-
quences of the procedure. Patients would probably benefit
from closer surveillance and support during the wound
healing process.
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